NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/12/2025
Voltar para busca
Dado oficial do USPTO
4D
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
06/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 10, 17, 40
Data de depósito
04/11/2021
Data de registro
26/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/12/2023
Última transação
06/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
HUSSAIN,TASNEEM
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "4D" forming a geometric solid with a shadow, shown as a partial square, beneath the solid. The top panel is curved toward the back of the solid. The front left panel forms a stylized numeral "4". The front right panel forms the letter "D".
Titulares e representantes
Titulares
4D Medicine Limited
Representantes
Diane B Melnick Practus LLP
Classificação técnica
Classes Nice
Classe 1Classe 10Classe 17Classe 40
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in the fields of health and medical research and product development; chemical auxiliaries and intermediate products, namely, chemicals for use in the fields of health and medical research and product development; unprocessed artificial resins and plastics for use in the fields of health and medical research and product development; biological and chemical compounds for use in the fields of health and medical product development; chemicals for use in medical and biotechnological product development; reagents for use in the fields of health and medical research and product development
Classe 10
Surgical apparatus and instruments; medical apparatus and instruments, namely, surgical apparatus and instruments for use in connection with biomaterials; structural parts and fittings for the aforesaid goods
Classe 17
Semi-processed synthetic resins; semi-processed plastic substances; semi-processed polymer resins; semi-worked plastic substances; resins and plastics in extruded form for use in further manufacturing; all of the aforementioned for use in the fields of health and medical research and product development
Classe 40
Treatment of biodegradable and bioresorbable material, namely, implanted medical devices and biomaterials; chemical treatment of resins for use in the fields of health and medical research and product development; processing of biopharmaceutical and pharmaceutical preparations; processing of chemicals and resins for use in the fields of health and medical research and product development; custom manufacture of medical products; advisory and consultancy services in respect of all of the foregoing
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/03/2024
FIMP
FINAL DISPOSITION PROCESSED
27/03/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/03/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
26/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2023
PUBO
PUBLISHED FOR OPPOSITION
10/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/09/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/09/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/08/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
30/08/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/03/2023
GNFR
FINAL REFUSAL E-MAILED
09/03/2023
CNFR
FINAL REFUSAL WRITTEN
09/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/01/2023
RFNP
REFUSAL PROCESSED BY IB
21/09/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/08/2022
RFRR
REFUSAL PROCESSED BY MPU
25/08/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/08/2022
CNRT
NON-FINAL ACTION WRITTEN
16/08/2022
DOCK
ASSIGNED TO EXAMINER
16/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 4D ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.